| 000 | 01738 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513215718.0 | ||
| 264 | 0 | _c20000831 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWurzer, G | |
| 245 | 0 | 0 |
_aIncreased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein. _h[electronic resource] |
| 260 |
_bCancer research _cAug 2000 |
||
| 300 |
_a4238-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClone Cells |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacokinetics |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aEmbryo, Mammalian |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xdeficiency |
| 650 | 0 | 4 |
_aProbenecid _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xbiosynthesis |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aHerceg, Z | |
| 700 | 1 | _aWesierska-Gadek, J | |
| 773 | 0 |
_tCancer research _gvol. 60 _gno. 15 _gp. 4238-44 |
|
| 999 |
_c10894415 _d10894415 |
||